Bind raises $70.5 million in IPO

Bind Therapeutics Inc. (NASDAQ:BIND) was off $0.91 to $14.09 in its first day of trading on Friday after raising $70.5 million through the sale of 4.7 million shares at $15 in an IPO. The price valued the company at $236.7 million. Credit Suisse; Cowen; Stifel; and JMP Securities are underwriters.

The price was the midpoint of the $14-$16 range Bind Therapeutics set earlier this month. Last month, Bind filed to raise up to $80.5 million. ...